Thus, we extracted public databases and found that the expression of EFNA4 was significantly upregulated in HCC patients with hepatitis B virus (GenBank: GSE121248) and hepatitis C virus infection (GenBank: GSE107170), followed by activation of some tumor-related signaling pathways. The gene discussed is EFNA4; the disease is hepatitis C virus infection.